Pitsanu Daengprasert, Chief Executive Officer of JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited, or JSP, disclosed that the company targets 10% revenue growth in 2026, surpassing 1 billion baht, driven by the preventive healthcare trend as consumers increasingly "eat before getting sick." As a result, vitamin C and bird's nest products under the Suphap Osot brand are selling well, especially during the rainy season. Meanwhile, the recovering tourism sector, particularly Chinese tourists traveling to Thailand during the Mid-Autumn Festival and ahead of China's National Day holiday, or Golden Week, in October, has significantly boosted sales of Thai herbal products. On operations, the company stated that flooding and heavy rain in Bangkok have not affected production, as its main factories are located in the Rama 3 area and Lamphun province, which are not in the affected zones, so production lines are running at full capacity to meet rising product demand. The company is also continuing to develop Suphap Osot brand products and expand distribution channels both domestically and overseas, both in-store and online, to increase the share of revenue from its own brand.
J.S.P. Property Public Company LimitedJSP targets 10% revenue growth past 1 billion baht in 2026 as preventive-health and Chinese-tourism demand lifts Suphap Osot vitamin C, bird's nest and herbal product sales.
